Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
about
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS studyThe economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United KingdomCognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management.Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy.Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
P2860
Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Epidemiology of progressive su ...... oup on Atypical Parkinsonisms.
@en
Epidemiology of progressive su ...... oup on Atypical Parkinsonisms.
@nl
type
label
Epidemiology of progressive su ...... oup on Atypical Parkinsonisms.
@en
Epidemiology of progressive su ...... oup on Atypical Parkinsonisms.
@nl
prefLabel
Epidemiology of progressive su ...... oup on Atypical Parkinsonisms.
@en
Epidemiology of progressive su ...... oup on Atypical Parkinsonisms.
@nl
P2093
P50
P356
P1476
Epidemiology of progressive su ...... oup on Atypical Parkinsonisms.
@en
P2093
European Study Group on Atypical Parkinsonism (ESGAP)
G De Michele
G Talarico
N Locuratolo
N Vanacore
P Lamberti
P Vieregge
V Bonifati
P2888
P304
P356
10.1007/S100720170065
P577
2001-02-01T00:00:00Z